No Influence on Cardiac Arrhythmia or Heart Rate from Long-Term Treatment with Tiotropium/Olodaterol versus Monocomponents by Holter ECG Analysis in Patients with Moderate-to-Very-... by Andreas S, Bothner U, de la Hoz A, Kloer I, Trampisch M, Alter P

Get full text

A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD by Andreas S, Bothner U, de la Hoz A, Kloer I, Trampisch M, Alter P

Get full text

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study by Ichinose M, Nishimura M, Akimoto M, Kurotori Y, Zhao Y, de la Hoz A, Mishima M

Get full text

TRONARTO: A Randomized, Placebo-Controlled Study of Tiotropium/Olodaterol Delivered via Soft Mist Inhaler in COPD Patients Stratified by Peak Inspiratory Flow by Mahler DA, Ludwig-Sengpiel A, Ferguson GT, de la Hoz A, Ritz J, Shaikh A, Watz H

Get full text

Absence of Adverse Effects of Tiotropium/Olodaterol Compared with the Monocomponents on Long-Term Heart Rate and Blood Pressure in Patients with Moderate-to-Very-Severe COPD by Andreas S, McGarvey L, Bothner U, Trampisch M, de la Hoz A, Fležar M, Buhl R, Alter P

Get full text

Fully automated flow protocol for C(sp3)–C(sp3) bond formation from tertiary amides and alkyl halides by Pijper, B, Martín, R, Huertas-Alonso, AJ, Linares, ML, López, E, Llaveria, J, Díaz-Ortiz, Á, Dixon, DJ, de la Hoz, A, Alcázar, J